Total planned funding: $876,032,367
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $165,508,557 |
Kenya | $156,390,788 |
Uganda | $146,139,261 |
Tanzania | $118,867,259 |
Zambia | $90,785,576 |
South Africa | $39,651,983 |
Mozambique | $34,557,743 |
Zimbabwe | $27,036,062 |
Rwanda | $26,558,475 |
Haiti | $20,890,859 |
Côte d'Ivoire | $13,862,449 |
Democratic Republic of the Congo | $11,672,026 |
Botswana | $7,687,092 |
Ethiopia | $7,010,000 |
Vietnam | $2,897,428 |
Namibia | $2,341,000 |
Eswatini | $1,970,493 |
Guyana | $772,197 |
Burundi | $715,195 |
South Sudan | $283,942 |
Cameroon | $163,101 |
Malawi | $138,000 |
Ukraine | $132,881 |
Lesotho | $0 |
Organizational Types
Private Contractor | $617,033,446 |
Host Country Government Agency | $80,249,895 |
Unknown | $68,832,624 |
NGO | $61,027,619 |
Implementing Agency | $23,931,260 |
FBO | $16,091,491 |
University | $4,224,263 |
Own Agency | $3,558,143 |
Parastatal | $1,073,626 |
Other USG Agency | $10,000 |
Multi-lateral Agency | $0 |
Program Areas
Treatment | $876,032,367 |
Budget Codes
HTXD: Treatment: ARV Drugs | $876,032,367 |
Top Partner Programs
Chemonics International:
$422,834,602
View countries